Canada's Valeant in talks to buy Bausch & Lomb for $9 bn
May 25, 2013 at 16:32 | Source:
Canadian drug maker Valeant Pharmaceuticals International is close to finalising a deal to acquire eye care company Bausch Lomb Holdings Inc from private equity firm Warburg Pincus, for about $9 billion, the Wall Street Journal yesterday reported, c...
Ireland's Elan rejects Royalty Pharma's sweetened $6.4 bn bid
May 24, 2013 at 21:32 | Source:
Irish neuroscience-focused biotechnology company Elan Corp yesterday rejected Royalty Pharma's sweetened $6.4 billion bid, saying that the revised offer continues to grossly undervalue the company and its future prospects. New York-based Royalty Pha...
Pfizer takes a shot at evasive superbug vaccine
May 23, 2013 at 12:02 | Source:
Chicago: Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis vaccine Prevnar 13...
Ranbaxy: Daiichi may sue Singh brothers for concealing key info
May 23, 2013 at 09:51 | Source:
New York Daiichi Sankyo, Japans No. 3 drug maker, which spent $4.2 billion in 2008 to acquire Ranbaxy just before its many problems became known, released its own statement saying certain former shareholders concealed and misrepresented critical info...
Cancer immunotherapy drugs will soon be a $35 bn global industry
May 22, 2013 at 17:33 | Source:
A new wave of medicines that tap the power of the immune system to fight cancer could become the biggest drug class in history, with potential sales of $35 billion a year.That bullish sales forecast by analysts at US bank Citigroup highlights the gro...
L'affaire Ranbaxy: Why is nobody bothered about Indians' safety?
May 22, 2013 at 12:07 | Source:
Ranabxy Laboratories just gave the US FDA a stick to beat all generics makers, a lot much loathed by the Big Pharma lobby.The fear in the US about the cheaper versions of medicines is palpable."As the Ranbaxy story makes vividly clear, generic-d...
Royalty Pharma raises offer to $6.4 bn for Irish drugmaker Elan
May 21, 2013 at 15:07 | Source:
Royalty Pharma, US firm that invests in royalty streams from pharmaceuticals, yesterday sweetened its offer to buy Elan Corp by 12 per cent to $6.4 billion although the Irish drugmaker continues to resist the takeover and splurges money from the sal...
Irish drugmaker Elan splurges $380 mn on two acquisitions
May 20, 2013 at 21:37 | Source:
Elan Corp, the Irish neuroscience-focused biotechnology company that is resisting a takeover bid from Royalty Pharma, has acquired two small rare disease drugmakers for $380 million. The Dublin-based company has acquired Vienna-based AOP Orphan Phar...
Markets snap 4-day winning streak, pharma biggest loser
May 20, 2013 at 16:08 | Source:
The Indian markets closed in the red today after opening in the green, weighed down by profit0booking in rate sensitive stocks.The BSE Sensex closed at20235.97, down0.25 percent while the Nifty closed at6161.75, down0.41 percent.Shares snapped a 4-da...
Market to take cues from FIIs inflows, corporate earnings
May 19, 2013 at 13:10 | Source:
Vikrant Shah MUMBAI: Both the benchmark indices Sensex and Nifty closed to new two-and-a-half-year highs as data showing a sharp fall in the wholesale price inflation in April 2013 raised hopes that the RBI may cut interest rates as early as next mon...
New pharma policy to hurt multinational firms more
May 18, 2013 at 00:17 | Source:
The Hindu BusinessLine
May 17, 2013: The new Drug Control Order 2013, which envisages capping the prices of 348 essential medicines, was notified on Thursday. The simple average price of drug brands with market share of more than one per cent will be fixed as the ceiling ...
BSE Sensex crawls to new 30-month high as cap goods shine
May 17, 2013 at 19:02 | Source:
Indices continued their upward crawl Friday, but it is clear that the market needs a bigger dose of liquidity to be able deliver meaningful returns hereon. Capital goods, power and realty shares were in demand, while investors shunned those from the...
Wockhardt, OIL, GSK Consumer Healthcare added to MSCI India index
May 17, 2013 at 13:47 | Source:
Apollo Hospitals, Oil India, Wockhardt and GlaxoSmithKline Consumer Healthcare have been added to the Morgan Stanley Capital International (MSCI) India index."The changes will take place after the close of trade on May 31," MSCI said in a statement....
BSE Sensex closes slightly up; bulls pause for a breather
May 17, 2013 at 13:47 | Source:
Shares crawled higher Thursday, as investors trade cautiously with benchmark indices quoting at their highest levels in nearly two-and-a-half years. Buyers shifted attention to mid-cap shares, as these are now beginning to look attractive relative t...
FII inflows to get better as MSCI India adds 4 stocks
May 17, 2013 at 11:26 | Source:
Foreign investor flows into Indian markets are set to get wider as MSCI Inc, the global benchmark indices construction agency, has included four more stocks in the MSCI India Index taking the total number to 76. The MSCI India index will include Apo...
Nifty gains on rate cut hopes, MSCI additions
May 17, 2013 at 03:15 | Source:
REUTERS - The Nifty rose to a 2-1/2 year high on Thursday, as lenders continued their rally on expectations of early rate cuts by the RBI, while four additions to the MSCI India index, including Wockhardt, also gained.Expectations the Reserve Bank of...
Sensex rises for 3rd day, up 34 pts as RIL, ICICI Bank gain
May 17, 2013 at 01:05 | Source:
Rising for third consecutive day, the BSE benchmark Sensex on Thursday advanced by 34 points to close at fresh 28-month high on good gains in heavyweight Reliance Industries and banking shares like ICICI Bank and HDFC Bank amid continued hopes of a ...
Apollo Hospitals, GSK Consumer gain on MSCI index rejig
May 16, 2013 at 21:52 | Source:
The Hindu BusinessLine
Chennai, May 16: Stocks of Apollo Hospitals, Oil India, Wockhardt and GlaxoSmithKline Consumer Healthcare gained between one and nine per cent on the bourses on Thursday after Morgan Stanley Capital International announced that they will be included...
Apollo, GlaxoSmithKline shares surge on MSCI inclusion
May 16, 2013 at 20:40 | Source:
NEW DELHI: Shares of Apollo Hospitals, GlaxoSmithKline Consumer Healthcare, Oil India and Wockhardt, which have been included in the MSCI India Index, today surged as much as 8 per cent. Stocks of Apollo Hospitals Enterprise and GlaxoSmithKline Cons...
MSCI India index adds Wockhardt, GlaxoSmithKline Consumer, Apollo Hospitals
May 16, 2013 at 19:12 | Source:
Apollo Hospitals, Oil India, Wockhardt and GlaxoSmithKline Consumer Healthcare have been added to the MSCI (Morgan Stanley Capital International) India index. The changes will take place after the close of trade on May 31, 2013, MSCI said in a state...